logo-loader
viewEMMAC Life Sciences

EMMAC Life Sciences expanding on its medical cannabis acquisitions in London, Portugal, and Spain

EMMAC Life Sciences CEO Antonio Costanzo sat down with Proactive at the Cannabis Europa: Transatlantic Forum in Toronto. 

The London, UK-based medical cannabis company has raised a total of £34 in the past year. It has cultivation operations in Portugal, with extraction and distribution in Spain and in the UK.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CytoDyn reveals its drug inhibits colon carcinoma metastases...

CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive its flagship drug leronlimab inhibited a human colon carcinoma cell line metastases to liver and lung in a well-accepted mouse model. Pourhassan says the company plans to file an IND for expanded access for a Phase 2 basket...

27 minutes ago

2 min read